Ruggeri F, Ciancimino C, Guillot A, Fumi D, Tizio F, Fragiotta S
Curr Issues Mol Biol. 2024; 46(2):1383-1397.
PMID: 38392207
PMC: 10887594.
DOI: 10.3390/cimb46020089.
Lykins J, Moschitto M, Zhou Y, Filippova E, Le H, Tomita T
iScience. 2024; 27(1):108477.
PMID: 38205261
PMC: 10776954.
DOI: 10.1016/j.isci.2023.108477.
Nitta K, Mukai R, Akiyama H
Am J Ophthalmol Case Rep. 2022; 25:101277.
PMID: 35112019
PMC: 8790631.
DOI: 10.1016/j.ajoc.2022.101277.
Labiano A, Arroyo M
GMS Ophthalmol Cases. 2020; 10:Doc04.
PMID: 32269902
PMC: 7113615.
DOI: 10.3205/oc000131.
Cremers F, Boon C, Bujakowska K, Zeitz C
Genes (Basel). 2018; 9(4).
PMID: 29659558
PMC: 5924557.
DOI: 10.3390/genes9040215.
Ornithine-δ-Aminotransferase Inhibits Neurogenesis During Xenopus Embryonic Development.
Peng Y, Cooper S, Li Y, Mei J, Qiu S, Borchert G
Invest Ophthalmol Vis Sci. 2015; 56(4):2486-97.
PMID: 25783604
PMC: 4554259.
DOI: 10.1167/iovs.15-16509.
A sensitive assay for ornithine amino transferase in rat brain mitochondria by ninhydrin method.
Ravi Kumar H, Ananda S, Devaraju K, Prakash B, Kumar S, Suresh Babu S
Indian J Clin Biochem. 2012; 24(3):275-9.
PMID: 23105849
PMC: 3453300.
DOI: 10.1007/s12291-009-0052-8.
Effect of pH on spectral characteristics of P5C-ninhydrin derivative: Application in the assay of ornithine amino transferase activity from tissue lysate.
Ravikumar H, Devaraju K, Shetty K
Indian J Clin Biochem. 2012; 23(2):117-22.
PMID: 23105736
PMC: 3453081.
DOI: 10.1007/s12291-008-0028-0.
Recent advances in the gene map of inherited eye disorders: primary hereditary diseases of the retina, choroid, and vitreous.
Rosenfeld P, MCKUSICK V, Amberger J, Dryja T
J Med Genet. 1994; 31(12):903-15.
PMID: 7891370
PMC: 1016688.
DOI: 10.1136/jmg.31.12.903.
Creatine metabolism and the consequences of creatine depletion in muscle.
Wyss M, Wallimann T
Mol Cell Biochem. 1994; 133-134:51-66.
PMID: 7808465
DOI: 10.1007/BF01267947.
Gyrate atrophy of the choroid and retina with hyperornithinemia. Deficient formation of guanidinoacetic acid from arginine.
Sipila I, Simell O, Arjomaa P
J Clin Invest. 1980; 66(4):684-7.
PMID: 7419715
PMC: 371642.
DOI: 10.1172/JCI109905.
Gyrate atrophy of the choroid and retina with hyperornithinemia: biochemical and histologic studies and response to vitamin B6.
Kennaway N, Weleber R, Buist N
Am J Hum Genet. 1980; 32(4):529-41.
PMID: 7395865
PMC: 1686127.
Gyrate atrophy of the choroid and retina: amino acid metabolism and correction of hyperornithinemia with an arginine-deficient diet.
Valle D, Walser M, Brusilow S
J Clin Invest. 1980; 65(2):371-8.
PMID: 7356686
PMC: 371375.
DOI: 10.1172/JCI109680.
Gyrate atrophy of the retina and choroid. Two methods for prenatal diagnosis.
ODonnell J, Sipila I, Vannas A, SANDMAN R
Int Ophthalmol. 1981; 4(1-2):33-6.
PMID: 7298261
DOI: 10.1007/BF00139578.
Clinical research methodology in ophthalmology.
Trans Am Ophthalmol Soc. 1980; 78:896-946.
PMID: 7257074
PMC: 1312162.
Treatment of gyrate atrophy of the choroid and retina with low arginine diet.
McInnes R, Arshinoff S, Bell L, McCulloch C
Trans Am Ophthalmol Soc. 1980; 78:226-42.
PMID: 7257057
PMC: 1312141.
Gyrate atrophy of the choroid and retina with hyperornithinemia: characterization of mutant liver L-ornithine:2-oxoacid aminotransferase kinetics.
Sipila I, Simell O, ODonnell J
J Clin Invest. 1981; 67(6):1805-7.
PMID: 7240420
PMC: 370761.
DOI: 10.1172/jci110222.
Presence of ornithine ketoacid aminotransferase in human ocular tissues.
Shiono T, Hayasaka S, Mizuno K
Graefes Arch Clin Exp Ophthalmol. 1982; 218(1):34-6.
PMID: 7056478
DOI: 10.1007/BF02134098.
Gyrate atrophy of the choroid and retina. Approaches to therapy.
Weleber R, Kennaway N, Buist N
Int Ophthalmol. 1981; 4(1-2):23-32.
PMID: 7028650
DOI: 10.1007/BF00139577.
Biochemical and therapeutical studies in a case of atrophia gyrata.
Behrens-Baumann W, Konig U, Schroder K, Hansmann I, Langenbeck U
Graefes Arch Clin Exp Ophthalmol. 1982; 218(1):21-4.
PMID: 6799362
DOI: 10.1007/BF02134094.